How to Trip Rapid Review

Step 1: Select articles relevant to your search (remember the system is only optimised for single intervention studies)

Step 2: press

Step 3: review the result, and maybe amend the or if you know better! If we're unsure of the overall sentiment of the trial we will display the conclusion under the article title. We then require you to tell us what the correct sentiment is.

1,021 results for

Fetal Heart Tracing

by
...
Latest & greatest
Alerts

Export results

Use check boxes to select individual results below

SmartSearch available

Trip's SmartSearch engine has discovered connected searches & results. Click to show

81. Accuracy of intrapartum fetal blood gas analysis by scalp sampling: A retrospective cohort study. Full Text available with Trip Pro

Accuracy of intrapartum fetal blood gas analysis by scalp sampling: A retrospective cohort study. Fetal blood gas analysis (FBGA) using scalp blood is commonly used to identify serious fetal distress. However, there is a lack of data regarding its accuracy and reliability. The aim of this study was to determine the positive predictive value (PPV) and negative predictive value (NPV) of FBGA for predicting postpartum acidosis in case of nonreassuring fetal heart rate tracings (NRFHRT (...) to determine the influence of cardiotocography variations and the time delay between FBGA and delivery on the accuracy of FBGA. We analyzed 343 deliveries with NRFHRT. In 32 (9%) of these cases, fetal acidosis was confirmed by a postpartum umbilical cord blood pH value ≤ 7.15. In 308/343 (90%) cases, FBGA identified NRFHRT as false positive (as confirmed by nonacidotic postpartum pH values) and thus avoided unnecessary interventions such as operative delivery. The overall test accuracy of FBGA was 91

2017 Medicine

82. Electronic Fetal Monitoring With and Without Pattern Interpretation

rate tracing is recorded on paper or electronically and produces a pattern to allow physicians to visually identify fetuses that are at risk for hypoxia and/or acidemia. This practice allows for prompt intervention via intrauterine resuscitation and expedited delivery if deemed necessary. National and international guidelines published by the International Federation of Gynecology and Obstetrics and American College of Obstetrics and Gynecology describe how fetal heart rate patterns obtained (...) , then their patient information will be collected. Their labor will be managed as in Phase 1 except that EFM will be interpreted and managed as per ACOG/FIGO guidelines using paper on which fetal heart tracings will be recorded. All other aspects of their care will proceed as per standard at Ayder Referral Hospital. Patients who require EFM will be asked to provide basic health and demographic information, along with collection of information on labor and delivery course, post-partum outcome, and neonatal

2017 Clinical Trials

83. Spontaneous Fetal EEG Recording During Labor

): Martin Frasch, University of Washington Study Details Study Description Go to Brief Summary: This is a pilot feasibility study for a new application of an approved fetal heart rate monitoring device system. The objective of this study is to validate the feasibility of acquiring the new modality of human fetal bioelectrical activity, EEG, derived from the routinely used scalp fetal heart rate (FHR) monitor. Condition or disease Pregnancy Abnormal Detailed Description: The investigators' objective (...) is to validate the feasibility of acquiring the new modality of human fetal bioelectrical activity, EEG, derived from the routinely used scalp FHR monitor. The investigators expect that in some newborns acidemia will be detected based on cord blood pH. In these babies, the investigators will trace back the EEG recordings to further validate whether the EEG - FHR patterns were predictive of this outcome. In fetal sheep model of human labour the investigators were able to see the onset of acidemia <55 min

2017 Clinical Trials

84. Novii External Fetal Monitoring Device

is critical for appropriate interpretation of the characteristics that identify risk. This is a prospective, randomized pragmatic trial comparing the Novii Fetal ECG/EMG system to external fetal heart rate and tocometry (standard of care) for the amount of time of interpretable fetal heart rate during labor. Randomization will occur in blocks based on BMI to control for the potential effect of BMI. Fetal heart rate tracings from both groups of women will be reviewed in a blinded fashion by experienced (...) External fetal heart rate monitoring Active Comparator: Standard of Care External Monitor A standard external monitor will be placed throughout labor and delivery, unless a provider or investigator determines that an internal device is necessary for a better signal. Device: External fetal heart rate monitoring External fetal heart rate monitoring Outcome Measures Go to Primary Outcome Measures : Amount of time in minutes with the interpretable fetal heart rate tracing during the course of labor. [ Time

2017 Clinical Trials

85. Effect of Administering Intravenous Magnesium Sulfate on Fetal Cardiotocography and Neonatal Outcome in Preeclamptic Patients

over 15-20 min. Maintenance dose: 2 gm/hr in 100 mL of IV infusion to be continued for 24 hours after delivery. Other Name: Magnisium sulfate Outcome Measures Go to Primary Outcome Measures : Fetal heart rate tracing [ Time Frame: 20 minutes after MgSO4 administration ] Settings on a CTG machine is standardised to enable a consistent approach of interpretation of traces. Paper speed of 3cm per minute is adopted Eligibility Criteria Go to Information from the National Library of Medicine Choosing (...) settings on machines will be labelled at commencement of tracing. Maternal heart rate will be recorded and noted on CTG. Following birth date, time and mode of delivery will be labelled on CTG. Magnesium Sulphate hepatahydrate administration: Magnesium sulphate will be administered by continuous intravenous infusion according to our hospital protocol as follows: Loading dose: 4-6 gm of magnesium sulphate diluted in 100 mL of IV fluid administered over 15-20 min. Maintenance dose: 2 gm/hr in 100 mL

2017 Clinical Trials

86. Association Between Fluid Administration, Oxytocin Administration, and Fetal Heart Rate Changes

fetal heart rate tracings during the first 60 minutes after the placement of epidural analgesia [ Time Frame: Request for labor analgesia up to the first 60 minutes after the epidural placement ] Eligibility Criteria Go to Information from the National Library of Medicine Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study (...) Association Between Fluid Administration, Oxytocin Administration, and Fetal Heart Rate Changes Association Between Fluid Administration, Oxytocin Administration, and Fetal Heart Rate Changes - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove one

2014 Clinical Trials

87. Diagnostic accuracy of fetal heart rate monitoring in the identification of neonatal encephalopathy. Full Text available with Trip Pro

case by gestational age and mode of delivery in a two-to-one fashion. The last hour of electronic fetal heart rate monitoring before delivery was evaluated by three obstetricians blinded to outcome.The differences in tracing category were not significantly different (neonates in the case group 10.3% I, 76.9% II, 12.8% III; neonates in the control group 9.0% I, 89.7% II, 1.3% III; P=.18). Bivariate analysis showed neonates in the case group had significantly increased late decelerations, total (...) Diagnostic accuracy of fetal heart rate monitoring in the identification of neonatal encephalopathy. To estimate the diagnostic accuracy of electronic fetal heart rate abnormalities in the identification of neonates with encephalopathy treated with whole-body hypothermia.Between January 1, 2007, and July 1, 2013, there were 39 neonates born at two hospitals within our system treated with whole-body hypothermia within 6 hours of birth. Neurologically normal control neonates were matched to each

2014 Obstetrics and Gynecology

88. Recognition and response to electronic fetal heart rate patterns: impact on newborn outcomes and primary cesarean delivery rate in women undergoing induction of labor. (Abstract)

rate tracings was associated with a significantly reduced rate of neonatal intensive care unit admission (3.8% vs 5.2%, P = .01) and Apgar score less than 7 at 1 and 5 minutes (4.9% vs 6.4%, P = .01, 0.6% vs 1.1%, P = .04). Compliance with an in-use checklist was associated with both a reduction in the rate of neonatal intensive care unit admission (2.9 vs 4.4, P = .00) and a reduction in the cesarean delivery rate (15.8% vs 18.8%, P = .00).Electronic fetal heart rate monitoring improves neonatal (...) Recognition and response to electronic fetal heart rate patterns: impact on newborn outcomes and primary cesarean delivery rate in women undergoing induction of labor. The objective of the study was to examine the clinical impact of specific fetal monitoring-related practices during induced labor.This was a prospective, nonrandomized study.We studied 14,398 women undergoing oxytocin induction of labor. A decrease in the infusion rate of oxytocin in the face of specified category II fetal heart

2014 American Journal of Obstetrics and Gynecology

89. Indefinite Fetal Heart Rate Pattern in a Patient with Vasa Previa: A Situation Where Guideline Is Inapplicable Full Text available with Trip Pro

was indeterminate according to an indefinite fetal heart rate tracing with regular decelerations. After emergent cesarean delivery, a ruptured vasa previa, traversing the fetal membrane, unsupported by either the umbilical cord or placental tissue, was clearly identified. Treatment decision-making is challenging in such patient with indefinite fetal heart rate pattern because limited data exist to guide management. Well-designed studies are needed to clarify the uncertainty about the effect of indefinite fetal (...) Indefinite Fetal Heart Rate Pattern in a Patient with Vasa Previa: A Situation Where Guideline Is Inapplicable Most fetal heart rate patterns can be interpreted accurately so that management decisions can be made correctly. How-ever, few fetal heart rate patterns are so ambiguous that the obstetricians cannot interpret them precisely. A 27-year-old woman at 38 weeks' gestation in her first pregnancy was admitted with heavy vaginal bleeding and decrease in fetal movements. Fetal status

2014 Iranian journal of public health

90. Evaluation of fetal wellbeing by antepartum fetal heart monitoring. Full Text available with Trip Pro

Evaluation of fetal wellbeing by antepartum fetal heart monitoring. The value of antenatal fetal heart rate monitoring was assessed in 301 patients. Tracings from each patient were classified as "reactive" or "non-reactive." Perinatal mortality, fetal distress in labour, caesarean section for fetal distress, and the incidence of low Apgar scores were all significantly increased in the non-reactive group.

1977 British medical journal

91. Assessing Cardiac Metabolism Full Text available with Trip Pro

computed tomography. Early research on cardiac metabolism has concentrated on energy substrate metabolism, aided by techniques to cannulate the coronary sinus in vivo and to perfuse the beating heart ex vivo. Several principles have arisen from these early experiments using precise chemical or radiotracer analyses. These studies have revealed the heart as a metabolic omnivore. There are few energy-providing substrates that the heart cannot degrade in the presence of oxygen to produce ATP, when (...) Assessing Cardiac Metabolism Assessing Cardiac Metabolism | Circulation Research Search Hello Guest! Login to your account Email Password Keep me logged in Search March 2019 March 2019 February 2019 February 2019 January 2019 January 2019 This site uses cookies. By continuing to browse this site you are agreeing to our use of cookies. Free Access article Share on Jump to Free Access article Assessing Cardiac Metabolism A Scientific Statement From the American Heart Association , MD, DPhil, FAHA

2016 American Heart Association

92. Current Diagnostic and Treatment Strategies for Specific Dilated Cardiomyopathies: A Scientific Statement From the American Heart Association Full Text available with Trip Pro

presented with more advanced HF and had a trend toward worse survival. 23 Analyses from MERIT- HR (Metoprolol Extended Release Randomized Intervention Trial in Heart Failure) 24 and CIBIS-II (Cardiac Insufficiency Bisoprolol Study) 25 suggested that female sex might be a significant independent predictor of survival in patients with HF, regardless of ischemic or nonischemic pathogen- esis. Further studies will need to be conducted to provide more insight into the role of sex in the prognosis of DCM (...) the heart, kidney, liver, and nervous system. Cardiac involvement has been predominantly noted in amyloid light chain (AL) amyloido- sis (also known as primary amyloidosis), hereditary, se- nile, and isolated atrial amyloidosis. The most common types of cardiac amyloidosis encountered in clinical prac- tice are AL, senile, and certain hereditary/familial types. 35 Once amyloid infiltration involves the heart, prognosis significantly worsens. Although senile and familial cardiac amyloidoses have

2016 American Heart Association

93. ASNC-SCCT-SNMMI Guideline for Cardiac SPECT/CT and PET/CT 1.0

ª 2013 by the Society of Nuclear Medicine and Molecular Imaging, Inc. DOI: 10.2967/jnumed.112.105155 CARDIAC SPECT/CT AND PET/CT ? Dorbala et al. 1485X. Radiation safety and ALARA issues 19 A. MPI dosimetry 19 B. MPI in the pregnant or potentially pregnant patient 19 C. MPI in the breast-feeding patient 19 D. Coronary CTA 20 XI. Conclusion 20 XII. References 20 XIII. Approval 23 PREAMBLE The Society of Nuclear Medicine and Molecular Imaging (SNMMI) is an international scienti?c and professional (...) coronary artery calcium scoring and coronary CT angiography (CTA). Hybrid SPECT/CT and PET/CT enable us to assess cardiac physiology along with cardiac and coronary anatomy (7–9). The use of CT-based transmission imaging and attenuation correction improvesthediagnosticaccuracyofmyocardialperfusionimaging (MPI),comparedwithnon–attenuation-correctedMPI(10).Atten- uation correction facilitates quantitative imaging of myocardial perfusion and metabolism. The assessment of anatomic coronary atherosclerotic

2015 Society of Nuclear Medicine and Molecular Imaging

94. Nonreassuring Fetal Status

-reassuring Fetal Heart Tracing Maternal position change Oxygen 8-10 liters per minute by Suppress labor Discontinue Consider holding pushing Consider SQ 0.25 mg Consider Consider expedited delivery Consider Obstetrics Neonatology or Pediatrics VII. References Images: Related links to external sites (from Bing) These images are a random sampling from a Bing search on the term "Nonreassuring Fetal Status." Click on the image (or right click) to open the source website in a new browser window. Related (...) . Definition (MSH) Deficient oxygenation of FETAL BLOOD. Concepts Disease or Syndrome ( T047 ) MSH SnomedCT 276638004 English In Utero Hypoxia , Fetal Hypoxia , fetal hypoxia (diagnosis) , fetal hypoxia , Fetal Hypoxia [Disease/Finding] , fetus hypoxia , HYPOXIA IN UTERO , Fetal hypoxia , Fetal hypoxia (disorder) , Hypoxia, Fetal Portuguese Hipóxia Fetal Swedish Syrebrist hos foster Czech fétus - hypoxie , fetální hypoxie Finnish Sikiön hypoksia Russian PLODA GIPOKSIIA , GIPOKSIIA PLODA , KISLORODNAIA

2018 FP Notebook

95. Reduced Fetal Movements

be aware of the potential association of decreased fetal movements with key risk factors such as FGR, small-for-gestational-age (SGA) fetus, placental insufficiency and congenital malfor- mations. If after discussion with the clinician it is clear that the woman does not have RFM, there are no other risk factors for stillbirth and there is the presence of a fetal heart rate on auscultation, she can be reassured. However, if the woman still has concerns, she should be advised to attend her maternity (...) is not confirmed, immediate referral for ultrasound scan assessment of fetal cardiac activity must be undertaken. If the encounter with the woman has been over the telephone and there is thus no additional reassurance of auscultation of the fetal heart, the woman should be advised to report for further assessment. Methods employed to detect SGA fetuses include abdominal palpation, measurement of symphysis–fundal height and ultrasound biometry. The RCOG guidelines on the investigation and management of the SGA

2011 Royal College of Obstetricians and Gynaecologists

96. Valvular Heart Disease

entities having participated in the development of this document: Associations: European Association of Echocardiography (EAE), European Association of Percutaneous Cardiovascular Interventions (EAPCI), Heart Failure Association (HFA) Working Groups: Acute Cardiac Care, Cardiovascular Surgery, Valvular Heart Disease, Thrombosis, Grown-up Congenital Heart Disease Councils: Cardiology Practice, Cardiovascular Imaging The content of these European Society of Cardiology (ESC) Guidelines has been published (...) on 02 April 201911.2.6. Management of bioprosthetic failure . . . . . . . . .2485 11.2.7. Heart failure . . . . . . . . . . . . . . . . . . . . . . . . .2487 12. Management during non-cardiac surgery . . . . . . . . . . . . .2487 12.1. Preoperative evaluation . . . . . . . . . . . . . . . . . . . . .2488 12.2. Speci?c valve lesions. . . . . . . . . . . . . . . . . . . . . . .2488 12.2.1. Aortic stenosis . . . . . . . . . . . . . . . . . . . . . . .2488 12.2.2. Mitral stenosis

2012 European Society of Cardiology

97. Contraction-Associated Maternal Heart Rate Decelerations: A Pragmatic Marker of Intrapartum Volume Status. (Abstract)

women with nonanomalous singleton gestations at 35 weeks of gestation or greater and a category 1 fetal heart rate (FHR) pattern from admission to epidural placement. Those lacking continuous maternal pulse oximetry data before epidural placement were excluded. Maternal heart rate tracings were evaluated for the presence of a contraction-associated heart rate deceleration pattern before epidural placement. Women with and without a contraction-associated heart rate deceleration pattern were compared (...) Contraction-Associated Maternal Heart Rate Decelerations: A Pragmatic Marker of Intrapartum Volume Status. To define and characterize a maternal contraction-associated heart rate deceleration pattern and evaluate its association with maternal volume status.We performed a prespecified secondary analysis of a prospectively collected cohort from a randomized controlled trial of maternal pulse pressure, epidural coload volume, and postepidural complications. Participants were healthy intrapartum

2018 Obstetrics and Gynecology Controlled trial quality: predicted high

98. Genetic Fate Mapping Defines the Vascular Potential of Endocardial Cells in the Adult Heart. Full Text available with Trip Pro

Genetic Fate Mapping Defines the Vascular Potential of Endocardial Cells in the Adult Heart. Endocardium is the major source of coronary endothelial cells (ECs) in the fetal and neonatal hearts. It remains unclear whether endocardium in the adult stage is also the main origin of neovascularization after cardiac injury.To define the vascular potential of adult endocardium in homeostasis and after cardiac injuries by fate-mapping studies.We generate an inducible adult endocardial Cre line (Npr3 (...) [natriuretic peptide receptor C]-CreER) and show that Npr3-CreER efficiently and specifically labels endocardial cells but not coronary blood vessels in the adult heart. The adult endocardial cells do not contribute to any vascular ECs during cardiac homeostasis. To examine the formation of blood vessels from endocardium after injury, we generate 4 cardiac injury models with Npr3-CreER mice: myocardial infarction, myocardial ischemia-reperfusion, cryoinjury, and transverse aortic constriction. Lineage

2018 Circulation Research

99. 2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease: Executive Summary

selected databases rele- vanttothisguideline.Keysearchwordsincludedbutwere not limited to the following: valvular heart disease, aortic stenosis, aortic regurgitation, bicuspid aortic valve, mitral stenosis, mitral regurgitation, tricuspid stenosis, tricuspid regurgitation, pulmonic stenosis, pulmonic regurgitation, prosthetic valves, anticoagulation therapy, infective endo- carditis, cardiac surgery, and transcatheter aortic valve replacement. Additionally, the committee reviewed docu- ments related (...) Anatomy Valve Hemodynamics Hemodynamic Consequences Symptoms A At risk of AR Bicuspid aortic valve (or other congenital valve anomaly) Aortic valve sclerosis Diseases of the aortic sinuses or ascending aorta History of rheumatic fever or known rheumatic heart disease IE AR severity: none or trace None None B Progressive AR Mild-to-moderate calci?cation of a trilea?et valve bicuspid aortic valve (or other congenital valve anomaly) Dilated aortic sinuses Rheumatic valve changes Previous IE

2014 Society for Cardiovascular Angiography and Interventions

100. Valvular Heart Disease: Guidelines For the Management of Patients With

Valvular Heart Disease: Guidelines For the Management of Patients With PRACTICE GUIDELINE 2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines Developed in Collaboration With the American Association for Thoracic Surgery, American Society of Echocardiography, Society for Cardiovascular Angiography and Interventions, Society of Cardiovascular Anesthesiologists (...) , FACC Susan J. Pressler, PHD, RN, FAHA Frank W. Sellke, MD, FACC, FAHA Win-Kuang Shen, MD, FACC, FAHA William G. Stevenson, MD, FACC, FAHAxx Clyde W. Yancy, MD, FACC, FAHAxx xxFormer Task Force member during the writing effort. This document was approved by the American College of Cardiology Board of Trustees and the American Heart Association Science Advisory and Coordinating Committee in January 2014. TheAmericanCollegeofCardiologyrequeststhatthisdocumentbecitedasfollows: Nishimura RA, Otto CM

2014 American College of Cardiology

To help you find the content you need quickly, you can filter your results via the categories on the right-hand side >>>>